Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes | Zendy

Emily Y. Chew | Zendy; Walter T. Ambrosius | Zendy; Matthew D. Davis | Zendy; Ronald P. Danis | Zendy; Sapna Gangaputra | Zendy; Craig M. Greven | Zendy; Larry D. Hubbard | Zendy; Barbara Esser | Zendy; James Lovato | Zendy; Letitia H. Perdue | Zendy; David C. Goff | Zendy; William C. Cushman | Zendy; Henry N. Ginsberg | Zendy; Marshall B. Elam | Zendy; Saul Genuth | Zendy; Hertzel C. Gerstein | Zendy; Ulrich K. Schubart | Zendy; Lawrence J. Fine | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes

Author(s) -

Emily Y. Chew,

Walter T. Ambrosius,

Matthew D. Davis,

Ronald P. Danis,

Sapna Gangaputra,

Craig M. Greven,

Larry D. Hubbard,

Barbara Esser,

James Lovato,

Letitia H. Perdue,

David C. Goff,

William C. Cushman,

Henry N. Ginsberg,

Marshall B. Elam,

Saul Genuth,

Hertzel C. Gerstein,

Ulrich K. Schubart,

Lawrence J. Fine

Publication year - 2010

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1001288

Subject(s) - medicine , glycemic , dyslipidemia , diabetic retinopathy , type 2 diabetes , retinopathy , diabetes mellitus , blood pressure , endocrinology

We investigated whether intensive glycemic control, combination therapy for dyslipidemia, and intensive blood-pressure control would limit the progression of diabetic retinopathy in persons with type 2 diabetes. Previous data suggest that these systemic factors may be important in the development and progression of diabetic retinopathy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research